Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C

NCT03416491 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: KW-136
DRUG: Sofosbuvir

Sponsor

Kawin Technology Share-holding Co., Ltd.

Collaborators

[object Object]